These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9860972)

  • 41. Prodrugs of dynemicin analogs for selective chemotherapy mediated by an aldolase catalytic Ab.
    Sinha SC; Li LS; Miller GP; Dutta S; Rader C; Lerner RA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3095-9. PubMed ID: 14981258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aldolase antibody activation of prodrugs of potent aldehyde-containing cytotoxics for selective chemotherapy.
    Sinha SC; Li LS; Watanabe S; Kaltgrad E; Tanaka F; Rader C; Lerner RA; Barbas CF
    Chemistry; 2004 Oct; 10(21):5467-72. PubMed ID: 15378729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Switchable cucurbituril-bipyridine beacons.
    Sinha MK; Reany O; Parvari G; Karmakar A; Keinan E
    Chemistry; 2010 Aug; 16(30):9056-67. PubMed ID: 20572166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of a catalytic tetrad during evolution of a highly active artificial aldolase.
    Obexer R; Godina A; Garrabou X; Mittl PR; Baker D; Griffiths AD; Hilvert D
    Nat Chem; 2017 Jan; 9(1):50-56. PubMed ID: 27995916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practical synthesis of 4-hydroxy-3-oxobutylphosphonic acid and its evaluation as a bio-isosteric substrate of DHAP aldolase.
    Arth HL; Fessner WD
    Carbohydr Res; 1997 Dec; 305(3-4):313-21. PubMed ID: 9648254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody catalysis of pericyclic reactions.
    Ulrich HD; Driggers EM; Schultz PG
    Acta Chem Scand (Cph); 1996 Apr; 50(4):328-32. PubMed ID: 8639375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite, Giardia lamblia.
    Galkin A; Kulakova L; Melamud E; Li L; Wu C; Mariano P; Dunaway-Mariano D; Nash TE; Herzberg O
    J Biol Chem; 2007 Feb; 282(7):4859-4867. PubMed ID: 17166851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of the Schiff base forming fructose-1,6-bisphosphate aldolase: structural analysis of reaction intermediates.
    Lorentzen E; Siebers B; Hensel R; Pohl E
    Biochemistry; 2005 Mar; 44(11):4222-9. PubMed ID: 15766250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reaction properties of catalytic antibodies encapsulated in organo substituted SiO2 sol-gel materials.
    Kato K; Saito T; Seelan S; Tomita M; Yokogawa Y
    J Biosci Bioeng; 2005 Oct; 100(4):478-80. PubMed ID: 16310742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic screening for catalytic promiscuity in 4-oxalocrotonate tautomerase: enamine formation and aldolase activity.
    Zandvoort E; Baas BJ; Quax WJ; Poelarends GJ
    Chembiochem; 2011 Mar; 12(4):602-9. PubMed ID: 21290551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
    Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A functional role for a flexible loop containing Glu182 in the class II fructose-1,6-bisphosphate aldolase from Escherichia coli.
    Zgiby S; Plater AR; Bates MA; Thomson GJ; Berry A
    J Mol Biol; 2002 Jan; 315(2):131-40. PubMed ID: 11779234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Engineering aldolases for asymmetric synthesis.
    Widersten M
    Methods Enzymol; 2020; 644():149-167. PubMed ID: 32943143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
    Popkov M; Rader C; Gonzalez B; Sinha SC; Barbas CF
    Int J Cancer; 2006 Sep; 119(5):1194-207. PubMed ID: 16570283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The antibody catalysis route to the total synthesis of epothilones.
    Sinha SC; Barbas CF; Lerner RA
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14603-8. PubMed ID: 9843936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aldolase-catalyzed synthesis of conformationally constrained iminocyclitols: preparation of polyhydroxylated benzopyrrolizidines and cyclohexapyrrolizidines.
    Laborda P; Sayago FJ; Cativiela C; Parella T; Joglar J; Clapés P
    Org Lett; 2014 Mar; 16(5):1422-5. PubMed ID: 24552164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity.
    Shamis M; Barbas CF; Shabat D
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1172-5. PubMed ID: 17234408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of the hydrophobic environment on the retro-aldol reaction: comparison to a computationally-designed enzyme.
    Schmidt J; Ehasz C; Epperson M; Klas K; Wyatt J; Hennig M; Forconi M
    Org Biomol Chem; 2013 Dec; 11(48):8419-25. PubMed ID: 24189834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant Snail Sialic Acid Aldolase is Promiscuous towards Aliphatic Aldehydes.
    Hu ZX; Cheng C; Li YQ; Qi XH; Wang T; Liu L; Voglmeir J
    Chembiochem; 2022 Jul; 23(13):e202200074. PubMed ID: 35543120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specificity of fructose-1, 6-P2 aldolase (muscle) and partition of the enzyme among catalytic intermediates in the steady state.
    Rose IA; O'Connell EL
    J Biol Chem; 1977 Jan; 252(2):479-82. PubMed ID: 833139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.